Status:
COMPLETED
Optimal Management of Women With Wrist Fractures
Lead Sponsor:
Queen's University
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Osteoporosis
Osteopenia
Eligibility:
FEMALE
50+ years
Phase:
NA
Brief Summary
To evaluate the effectiveness of a multifaceted intervention (reminder and educational material) in improving the evaluation of osteoporosis follow-up care of post-menopausal women with wrist fracture...
Detailed Description
Numerous studies have demonstrated that women with wrist fractures have lower bone mineral density. Despite new guidelines for the care of such women, research has shown that they are not generally ev...
Eligibility Criteria
Inclusion
- Postmenopausal women with low trauma distal radius fracture (confirmed by x-ray).
- Can be taking Didrocal (etidronate), Miacalcin (calcitonin),or hormone replacement therapy .
Exclusion
- Women with fractures of the elbow, mid radius, scaphoid, or injury to wrists (without actual fracture).
- Significant cognitive impairment (which would preclude them from filling out simple questionnaires).
- Women already taking osteoporosis therapy, ie. either Fosamax (alendronate), Actonel (risedronate), or the selective estrogen receptor modulator, Evista (raloxifene).
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT00226031
Start Date
September 1 2003
End Date
August 1 2007
Last Update
March 11 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen's University
Kingston, Ontario, Canada, K7L 3N6